Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Phreesia, Inc. (NYSE: PHR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Phreesia securities between May 8, 2025 and March 30, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/PHR.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Phreesia was experiencing slowing demand and diminished visibility into key revenue streams; (2) the Company’s Network Solutions segment was facing weakened pharmaceutical marketing commitments; and (3) as a result, Defendants’ positive statements about Phreesia’s business, operations, and prospects lacked a reasonable basis and were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/PHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911 . If you suffered a loss in Phreesia you have until July 13, 2026, to request that the Cour...